Science Explorer Back to mapMap

Most cited papers from Texas Digestive Disease Consultants

What are the most cited papers from Texas Digestive Disease Consultants?

The most cited paper from Texas Digestive Disease Consultants is "American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts" (Santhi Swaroop Vege, Barry S. Ziring, Rajeev Kumar Jain et al., 2015), with 1,155 citations. Next come "Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options" (1,093) and "NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial" (420).

Showing 50 of 59 papers. Every paper with more than 2 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts Santhi Swaroop Vege, Barry S. Ziring, Rajeev Kumar Jain et al. · Gastroenterology Open access 21 Mar 2015 1,155
2 Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options Ira M. Jacobson et al. · New England Journal of Medicine Open access 23 Apr 2013 1,093
3 NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Stephen A. Harrison, Mary Eugenia Rinella, Manal F. Abdelmalek et al. · The Lancet Mar 2018 420
4 Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group Uma Mahadevan, Christopher James Robinson, Nana Bernasko et al. · Gastroenterology Open access 16 Jan 2019 355
5 Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial Xavier Forns, Samuel S. Lee, Joaquin M. Valdes et al. · The Lancet Infectious Diseases 15 Aug 2017 348
6 Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial Keyur Patel et al. · Hepatology 2 Mar 2020 336
7 Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis Stephen A. Harrison, Guy W. Neff, Cynthia D. Guy et al. · Gastroenterology Open access 8 Aug 2020 271
8 NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis Stephen A. Harrison, Stephen J. Rossi, Angelo H. Paredes et al. · Hepatology Open access 26 Feb 2019 260
9 TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial Rohit Seth Loomba, Rizwana Mohseni, Kathryn Jean Lucas et al. · Gastroenterology Open access 23 Jul 2021 225
10 Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial Gideon Morris Hirschfield, Olivier Chazouillères, Joost P.H. Drenth et al. · Journal of Hepatology Open access 8 Nov 2018 185
11 EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield Paul S. Sepe, Bhavani Moparty, Martha B. Pitman et al. · Gastrointestinal Endoscopy 31 May 2009 181
12 Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study Brian L. Bressler, Andres J. Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis Open access 25 Mar 2021 148
13 Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy Bruce D. Greenwald, John A. Dumot, Julian A. Abrams et al. · Gastrointestinal Endoscopy Open access Apr 2010 148
14 The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis of Eosinophilic Esophagitis Jennifer A. Nielsen, Donna J. Lager, Matthew R. Lewin et al. · The American Journal of Gastroenterology 21 Jan 2014 134
15 Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA Jason Y. Park, Kerry B. Dunbar, Midori Mitui et al. · Digestive Diseases and Sciences 29 Feb 2016 87
16 Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis Mary Eugenia Rinella, James F. Trotter, Manal F. Abdelmalek et al. · Journal of Hepatology Open access 8 Dec 2018 80
17 Budd‐chiari syndrome causing acute liver failure: A multicenter case series Justin R. Parekh, Vlad M. Matei, Alejandro Cañas-Coto et al. · Liver Transplantation Open access 22 Sep 2016 74
18 Prognostic significance of red blood cell distribution width in gastrointestinal disorders Hemant Goyal, Giuseppe Lippi, Altin Gjymishka et al. · World Journal of Gastroenterology Open access 2017 71
19 Lymphocytic Gastritis is not Associated with active H elicobacter pylori Infection Jennifer A. Nielsen, Cory Anthony Roberts, Donna J. Lager et al. · Helicobacter 14 May 2014 46
20 Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection Stefan Zeuzem et al. · Journal of Hepatology Open access 16 Oct 2015 43
21 A Bundled Payment Framework for Colonoscopy Performed for Colorectal Cancer Screening or Surveillance Joel V. Brill, Rajeev Kumar Jain, Peter S. Margolis et al. · Gastroenterology 28 Jan 2014 41
22 Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort Cayden Beyer, Chloe Hutton, Anneli Andersson et al. · PLoS ONE Open access Apr 2021 32
23 Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice Matthew McMillin, Cheryl Galindo, Hae Yong Pae et al. · Journal of Hepatology Open access 19 Jul 2014 30
24 Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice Niels Vande Casteele, Brian G. Feagan, Douglas C. Wolf et al. · Inflammatory Bowel Diseases Open access 14 Oct 2020 24
25 Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients Mindie H. Nguyen, Huy Ngoc Trinh, Son Do et al. · The American Journal of Gastroenterology 31 Oct 2017 22
26 Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Alexander Lee, Vivek Kadiyala, Linda Lee · Endoscopy International Open Open access Feb 2017 20
27 Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation Fredric David Gordon, Paul Yien Kwo, Reem H. Ghalib et al. · Journal of Clinical Gastroenterology 27 Jun 2012 20
28 Incidence of Diagnostic Change in Colorectal Polyp Specimens After Deeper Sectioning at 2 Different Laboratories Staffed by the Same Pathologists Jennifer A. Nielsen, Donna J. Lager, Matthew R. Lewin et al. · American Journal of Clinical Pathology Open access 29 Jul 2013 18
29 Comparison of endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography outcomes using various technical approaches Firas Bahdi, Rollin George, Kavea Paneerselvam et al. · Endoscopy International Open Open access Apr 2022 13
30 Kombucha-Induced Massive Hepatic Necrosis: A Case Report and a Review of Literature Shilpa Kala Sannapaneni, Sarah Philip, Amit Desai et al. · Gastro Hep Advances Open access 3 Oct 2022 12
31 Frequency of metastasis to the gastrointestinal tract determined by endoscopy in a community-based gastroenterology practice Vishal Kaila, Rajeev Kumar Jain, Donna J. Lager et al. · Baylor University Medical Center Proceedings Open access 16 Jul 2021 12
32 Medicare’s Revaluation of Gastrointestinal Endoscopic Procedures: Implications for Academic and Community-Based Practices Spencer D. Dorn, Christopher J. Vesy · Clinical Gastroenterology and Hepatology 16 Apr 2016 11
33 Adherence to colorectal cancer screening with multi-target stool DNA testing among first-time average-risk users in federally qualified health centers Mallik Greene, Timo Pew, Lakshya Sakthisivabalan et al. · Current Medical Research and Opinion Open access 3 Jun 2025 9
34 Introducing the Gastroenterologist-accountable Professionalism in Practice (G-APP) Pathway: Bridging the G-APP-Replacing MOC With a Model for Lifelong Learning and Accountability Suzanne A. Rose, Brijen J. Shah, Jane E. Onken et al. · Gastroenterology Open access 19 Aug 2015 9
35 Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19 Alireza FakhriRavari, Mazyar Malakouti · Pharmacoepidemiology ReviewOpen access 13 Feb 2024 7
36 Staffing at Ambulatory Endoscopy Centers in the United States: Practice, Trends, and Rationale Deepak Agrawal, Rajeev Kumar Jain · Gastroenterology Research and Practice Open access 13 Sep 2018 7
37 Safety and efficacy of entecavir in adefovir‐experienced patients Nghia H. Nguyen, Huy Ngoc Trinh, Thuan Thi Nguyen et al. · Journal of Gastroenterology and Hepatology 28 Aug 2014 7
38 Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type Mallik Greene, Brad Stieber, Joseph William LeMaster et al. · Current Medical Research and Opinion Open access 2 Sep 2025 6
39 Gastric Cancer and Its Precursor Lesions: Unraveling the Diversity in Asian Risk Profiles Robert M. Genta, Anuradha Singhal, Christie Choi et al. · Clinical Gastroenterology and Hepatology 24 May 2024 6
40 Future of Cholangioscopy Jorge D. Machicado, Isaac L. Raijman, Raj J. Shah · Gastrointestinal Endoscopy Clinics of North America 11 May 2022 6
41 Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy Timothy E. Ritter, Chris Fourment, Tracy C. Okoro et al. · The American Journal of Gastroenterology Oct 2018 6
42 Collaborative Colorectal Cancer Screening: A Successful Quality Improvement Initiative Joyce Stroud, Chris Felton, Barbara Spreadbury · Baylor University Medical Center Proceedings Open access Jul 2003 6
43 Maintenance of Certification—The Value to Patients and Physicians Robert O. Roswell, Erica N. Johnson, Rajeev Kumar Jain · JAMA 5 Feb 2024 5
44 A Case for Abandoning Inpatient Fecal Occult Blood Testing Gregory Thomas Brennan, Andrew S. Parsons · Cureus Open access 24 Jun 2020 5
45 Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned Anita Afzali, Matthew A. Ciorba, David A. Schwartz et al. · Inflammatory Bowel Diseases 19 Dec 2017 5
46 Upper Gastrointestinal Bleeding Caused by Aortoesophageal Fistula George V. Nazarewicz, Rajeev Kumar Jain · Clinical Gastroenterology and Hepatology 22 Aug 2016 5
47 Zayıf Kayaçlarda Makinalı Kazı Performansının Kestirilmesindeki Zorluklar Evren Poşluk, Mustafa Korkanç · Jeoloji Mühendisliği Dergisi Open access 20 Nov 2018 4
48 Surgical management of gastric varices and morbid obesity: a novel approach Derick J. Christian, Amit S. Khithani, Manuel E. Castro-Arreola et al. · Surgery for Obesity and Related Diseases 29 Apr 2010 4
49 Needle-knife incision and drainage of duodenal intramural hematoma relieving duodenal and biliary obstruction Bakht S. Cheema, Yusuke Hashimoto · VideoGIE Open access 21 Jul 2023 3
50 A rare case of Wernicke encephalopathy in stage IV gastric cancer Arya Nikjoo, Hytham Rashid, Randy Chung et al. · Neurocase 2 Jan 2022 3

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.